KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Opko Health (OPK) over the last 15 years, with Q3 2025 value amounting to $11.4 million.

  • Opko Health's Interest Expenses fell 3457.0% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.4 million, marking a year-over-year increase of 20369.98%. This contributed to the annual value of $47.5 million for FY2024, which is 25143.64% up from last year.
  • According to the latest figures from Q3 2025, Opko Health's Interest Expenses is $11.4 million, which was down 3457.0% from $70.3 million recorded in Q2 2025.
  • Opko Health's Interest Expenses' 5-year high stood at $70.3 million during Q2 2025, with a 5-year trough of $2.7 million in Q1 2022.
  • In the last 5 years, Opko Health's Interest Expenses had a median value of $4.3 million in 2021 and averaged $10.0 million.
  • Per our database at Business Quant, Opko Health's Interest Expenses tumbled by 5065.8% in 2022 and then surged by 75974.33% in 2025.
  • Opko Health's Interest Expenses (Quarter) stood at $4.3 million in 2021, then dropped by 23.35% to $3.3 million in 2022, then rose by 4.57% to $3.5 million in 2023, then surged by 312.4% to $14.2 million in 2024, then decreased by 20.24% to $11.4 million in 2025.
  • Its Interest Expenses was $11.4 million in Q3 2025, compared to $70.3 million in Q2 2025 and $15.5 million in Q1 2025.